Viewing Study NCT05892068


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-25 @ 3:14 PM
Study NCT ID: NCT05892068
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2023-05-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module